Suppr超能文献

新生儿溶酶体贮积症

Lysosomal storage disorders in the newborn.

作者信息

Staretz-Chacham Orna, Lang Tess C, LaMarca Mary E, Krasnewich Donna, Sidransky Ellen

机构信息

Office of the Clinical Director, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Building 35, Room 1A213, 35 Convent Dr, MSC 3708, Bethesda, MD 20892-3708, USA.

出版信息

Pediatrics. 2009 Apr;123(4):1191-207. doi: 10.1542/peds.2008-0635.

Abstract

Lysosomal storage disorders are rare inborn errors of metabolism, with a combined incidence of 1 in 1500 to 7000 live births. These relatively rare disorders are seldom considered when evaluating a sick newborn. A significant number of the >50 different lysosomal storage disorders, however, do manifest in the neonatal period and should be part of the differential diagnosis of several perinatal phenotypes. We review the earliest clinical features, diagnostic tests, and treatment options for lysosomal storage disorders that can present in the newborn. Although many of the lysosomal storage disorders are characterized by a range in phenotypes, the focus of this review is on the specific symptoms and clinical findings that present in the perinatal period, including neurologic, respiratory, endocrine, and cardiovascular manifestations, dysmorphic features, hepatosplenomegaly, skin or ocular involvement, and hydrops fetalis/congenital ascites. A greater awareness of these features may help to reduce misdiagnosis and promote the early detection of lysosomal storage disorders. Implementing therapy at the earliest stage possible is crucial for several of the lysosomal storage disorders; hence, an early appreciation of these disorders by physicians who treat newborns is essential.

摘要

溶酶体贮积症是罕见的先天性代谢缺陷病,活产婴儿中的合并发病率为1/1500至1/7000。在评估患病新生儿时,这些相对罕见的疾病很少被考虑。然而,超过50种不同的溶酶体贮积症中有相当一部分在新生儿期就会出现症状,应作为几种围产期表型鉴别诊断的一部分。我们回顾了新生儿期可能出现的溶酶体贮积症的最早临床特征、诊断测试和治疗选择。虽然许多溶酶体贮积症具有多种表型,但本综述的重点是围产期出现的特定症状和临床发现,包括神经、呼吸、内分泌和心血管表现、畸形特征、肝脾肿大、皮肤或眼部受累以及胎儿水肿/先天性腹水。对这些特征有更多的认识可能有助于减少误诊并促进溶酶体贮积症的早期发现。对于几种溶酶体贮积症来说,尽早实施治疗至关重要;因此,治疗新生儿的医生尽早认识这些疾病至关重要。

相似文献

1
Lysosomal storage disorders in the newborn.新生儿溶酶体贮积症
Pediatrics. 2009 Apr;123(4):1191-207. doi: 10.1542/peds.2008-0635.
4
Perinatal-lethal Gaucher disease presenting as hydrops fetalis.表现为胎儿水肿的围产期致死性戈谢病。
Pan Afr Med J. 2015 Jun 10;21:110. doi: 10.11604/pamj.2015.21.110.7052. eCollection 2015.
8
Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly.溶酶体贮积症作为肝脾肿大的鉴别诊断。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):619-28. doi: 10.1016/j.bpg.2010.09.001.
10
Prenatal diagnosis of lysosomal storage diseases using fetal blood.利用胎儿血液进行溶酶体贮积病的产前诊断。
Prenat Diagn. 1999 Oct;19(10):930-3. doi: 10.1002/(sici)1097-0223(199910)19:10<930::aid-pd664>3.0.co;2-x.

引用本文的文献

4
Lysosomal storage disorders: from biology to the clinic with reference to India.溶酶体贮积症:结合印度情况从生物学进展到临床应用
Lancet Reg Health Southeast Asia. 2022 Nov 21;9:100108. doi: 10.1016/j.lansea.2022.100108. eCollection 2023 Feb.
9
Ascites in infantile onset type II Sialidosis.婴儿期发病的II型唾液酸贮积症中的腹水。
JIMD Rep. 2022 Jun 3;63(4):316-321. doi: 10.1002/jmd2.12305. eCollection 2022 Jul.

本文引用的文献

3
Hematopoietic cell therapy for metabolic disease.用于代谢性疾病的造血细胞疗法。
J Pediatr. 2007 Oct;151(4):340-6. doi: 10.1016/j.jpeds.2007.04.054.
5
Gaucher disease.戈谢病
Curr Opin Chem Biol. 2007 Aug;11(4):412-8. doi: 10.1016/j.cbpa.2007.05.035. Epub 2007 Jul 23.
6
Novel therapeutic targets for the treatment of Fabry disease.治疗法布里病的新型治疗靶点。
Expert Opin Ther Targets. 2007 Jun;11(6):821-33. doi: 10.1517/14728222.11.6.821.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验